Data Development Officer
European Union Drugs Agency (EUDA) - Deadline 24 August 2026 Data Development Officer The European Union Drugs Agency (EUDA) is recruiting a Data Development Officer to support its Early Warning, Alert and Laboratory Network. The role focuses on collecting, managing, [...]Part-time Program Manager
CEU Democracy Institute Leadership Academy - Open until filled Part-time Program Manager The CEU Democracy Institute is seeking a part-time Program Manager for its Democracy Institute Leadership Academy (DILA), a regional leadership initiative supporting democratic public leadership and civic engagement. [...]
The Human Cost Of Policy Shifts: A World In Turmoil.
International Network of People who Use Drugs (INPUD) – 21 July 2026
The Human Cost Of Policy Shifts: A World In Turmoil.
Fourteen months after the withdrawal of U.S. foreign assistance, this report examines the escalating impact of funding cuts on harm reduction and community-led services worldwide. Based on a global survey, it documents worsening financial instability, widespread service disruptions, and reduced access to HIV, hepatitis C, and overdose prevention. It also highlights how increasingly punitive policy environments are driving people who use drugs further from essential services and calls for urgent, sustained investment in community-led harm reduction.
Commissioner Kamarulzaman Speaks at Human Rights Council Side Event on Decriminalization and HIV
3 July 2026 – Geneva, Switzerland and Online Commissioner Kamarulzaman delivered remarks at the Human Rights Council (HRC) side event, “Human Rights Implications of Drug Policy: Decriminalizing Drug Use in HIV Response – A Guidance Note”. Photo credit: Global Commission [...]
The New EU Drugs Strategy: Failure to Consult, Lack of Balance, and Reliance on Outdated Concepts
Viktor Mravcik, Jana Michailidu, Vendula Belackova, et al. – 23 June 2026
The New EU Drugs Strategy: Failure to Consult, Lack of Balance, and Reliance on Outdated Concepts
The article, with contributions from Global Commission on Drug Policy Commissioner Pavel Bém, analyzes the European Union’s new Drugs Strategy and Action Plan Against Drug Trafficking. It examines the strategy’s development process, stakeholder consultation, and the balance between supply reduction measures and public health approaches. The analysis reviews the positioning of harm reduction, consideration of alternative regulatory models, and the continued emphasis on prohibition and law enforcement within the broader context of evolving drug policy approaches.
